|
FOR IMMEDIATE RELEASE
October 9, 2006
CONTACT: Michael Williams
Amerita, Inc.
(949) 387-5080
mwilliams@ameritaiv.com
ACCESS THERAPEUTICS INFUSION JOINS AMERITA, INC. AND IS POISED FOR GROWTH IN
SPECIALTY INFUSION MARKET
Access Therapeutics Infusion partners with Amerita, Inc. to expand clinical
programs in South Texas under local management.
Irvine, California, October 9, 2006 – Amerita, Inc. announced it has
acquired Access Therapeutics Infusion located at 1919 Oakwell Farms Parkway,
Suite 160 in San Antonio. According to the company, the acquisition is a strategic
investment that retains local management while helping extend the reach of
quality specialty infusion services to patients in the south Texas area.
Specialty infusion therapy services primarily involve the intravenous administration
of medications that treat a wide range of acute and chronic health conditions
such as infections, auto-immune illnesses, cancer, pain, multiple sclerosis,
hemophilia and nutritional deficiencies. To ensure quality, medications are
compounded in a sterile clean room, dispensed under the supervision of a local
registered pharmacist and delivered directly to the home of the patient. A
registered nurse then ensures safe administration of the medication.
“We chose to partner with Amerita because they understand that in the
service business, you’re only as good as your employees,” said
co-founder of Access Therapeutics Infusion, Greg McLain.
Co-founder Sharon Daugherty, RPh, said, “Unlike large national providers
that consolidate companies and lay-off employees, Amerita wanted to keep our
staff, provide them with better benefits, and help us grow our business in
southern Texas.”
According to Amerita CEO, Jim Glynn, Access Therapeutics Infusion will continue
to be locally managed by company founders Greg McLain and Sharon Daugherty,
RPh, and the current staff will be retained. “We’re excited about
our investment in Access Therapeutics Infusion and the opportunity to expand
quality specialty infusion services into the south Texas market, said Glynn. “The
ability to service patients in the San Antonio market will complement our existing
operations in Amarillo and Dallas and moves us closer to our vision of becoming
a State-wide provider of specialty infusion services in Texas.”
According to Glynn, Amerita’s business model is to acquire specialty
infusion service companies like Access Therapeutics Infusion that have great
clinical and service reputations and then continue to locally manage the business
to assure the responsiveness, quality and personal touch that customers expect.
Being part of a larger business provides increased cost efficiencies and improved
purchasing power so that local businesses can compete against national providers
today and in the future, said Glynn.
Amerita, Inc. www.ameritaiv.com is a privately held
Specialty Infusion company focused on providing complex pharmaceutical products
and clinical services to patients outside of the hospital. This market is expanding
rapidly and is driven by increasing healthcare costs, a growing bio-pharmaceutical
pipeline of infuseable and injectable medications and an aging population.
Amerita is headquartered at 20 Fairbanks, Suite 173, Irvine, CA 92618. Phone:
(949) 273-6528 / Fax: (949) 273-6547
# # #
|
